TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU

Interest has recently been aroused in generic drugs because of the reduction of government expenditures on treatment. These drugs must meet the same standards of quality, effectiveness, and safety as those for original medicines. The paper discusses the concepts of biological and pharmaceutical drug...

Full description

Saved in:
Bibliographic Details
Main Authors: Nataliya Vladimirovna Toroptsova, O A Nikitinskaya
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2011-03-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/333
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691467429183488
author Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
author_facet Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
author_sort Nataliya Vladimirovna Toroptsova
collection DOAJ
description Interest has recently been aroused in generic drugs because of the reduction of government expenditures on treatment. These drugs must meet the same standards of quality, effectiveness, and safety as those for original medicines. The paper discusses the concepts of biological and pharmaceutical drug equivalence, which permit original and generic drugs to be equalized in rights. Bioequivalence is considered using as an example alendronate that is extensively used to treat osteoporosis.
format Article
id doaj-art-421e11faa97a48f8b705a1d57c07cb86
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2011-03-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-421e11faa97a48f8b705a1d57c07cb862025-08-20T03:21:00ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2011-03-0151283210.14412/1996-7012-2011-6481638TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRUNataliya Vladimirovna ToroptsovaO A NikitinskayaNataliya Vladimirovna ToroptsovaO A NikitinskayaInterest has recently been aroused in generic drugs because of the reduction of government expenditures on treatment. These drugs must meet the same standards of quality, effectiveness, and safety as those for original medicines. The paper discusses the concepts of biological and pharmaceutical drug equivalence, which permit original and generic drugs to be equalized in rights. Bioequivalence is considered using as an example alendronate that is extensively used to treat osteoporosis.https://mrj.ima-press.net/mrj/article/view/333generic drugsbioequivalencepharmaceutical drug equivalencealendronate
spellingShingle Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
Nataliya Vladimirovna Toroptsova
O A Nikitinskaya
TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
Современная ревматология
generic drugs
bioequivalence
pharmaceutical drug equivalence
alendronate
title TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
title_full TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
title_fullStr TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
title_full_unstemmed TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
title_short TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
title_sort treatment of osteoporosis clinical experience in using a generic dru
topic generic drugs
bioequivalence
pharmaceutical drug equivalence
alendronate
url https://mrj.ima-press.net/mrj/article/view/333
work_keys_str_mv AT nataliyavladimirovnatoroptsova treatmentofosteoporosisclinicalexperienceinusingagenericdru
AT oanikitinskaya treatmentofosteoporosisclinicalexperienceinusingagenericdru
AT nataliyavladimirovnatoroptsova treatmentofosteoporosisclinicalexperienceinusingagenericdru
AT oanikitinskaya treatmentofosteoporosisclinicalexperienceinusingagenericdru